Thanks! Here is what Joe said - From Page 3
Post# of 36537
(Total Views: 253)
Posted On: 12/06/2019 6:19:44 PM
Re: homerbedloe #9784
Thanks!
Here is what Joe said -
From Page 3 of the 11/29/19 cc
Joe said –
As it pertains to NGIO's spin-off, as reported, our operating company public vehicle was acquired and we are working on the audits and nearing the corner on completing all the legal work necessary to bring this public and your NGIO shares to trading.
From Page 8 of the 11/29/19 cc
Joe said –
Well, there's really no delay there. I mean, obviously, when you're dealing with auditors, and you're dealing with lawyers and outside lawyers, they have other work, they have other stuff. Our goal is to get this thing public as soon as possible; I would love to have had it public at the same time we gave the dividend--which is right about now--
but we're close, we're really close. And that's our biggest goal, it's to get NuGenerex Immuno-Oncology public. That would put a huge asset on our books, it'll give us a liquid asset, and in my
opinion, it'll be unbelievably value-oriented for our shareholders. That is our biggest goal, to get that public
Here is what Joe said -
From Page 3 of the 11/29/19 cc
Joe said –
As it pertains to NGIO's spin-off, as reported, our operating company public vehicle was acquired and we are working on the audits and nearing the corner on completing all the legal work necessary to bring this public and your NGIO shares to trading.
From Page 8 of the 11/29/19 cc
Joe said –
Well, there's really no delay there. I mean, obviously, when you're dealing with auditors, and you're dealing with lawyers and outside lawyers, they have other work, they have other stuff. Our goal is to get this thing public as soon as possible; I would love to have had it public at the same time we gave the dividend--which is right about now--
but we're close, we're really close. And that's our biggest goal, it's to get NuGenerex Immuno-Oncology public. That would put a huge asset on our books, it'll give us a liquid asset, and in my
opinion, it'll be unbelievably value-oriented for our shareholders. That is our biggest goal, to get that public
(0)
(1)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼